About
Members
Data & Intelligence
VC+Tech
Newsroom
Training & Events
Regions

Remember me!

Forgot username or password?

Don't have an account Sign up!

Industry Newsroom

Industry News
- NewsWatch
- VC+Tech
EMPEA News
- EMPEA in the News
- Press Releases
Member News
Media Resources
Sign up for Communications

SPE Capital and Proparco Acquire Morocco’s Pharmaceutical Company Saham Pharma

Posted On: 09 Apr 2020 | Source(s): SPE Capital Partners

Africa- and Middle East-focused private equity firm SPE Capital Partners has acquired Morocco-based antibiotics manufacturer and hospital provider Saham Pharma through SPE AIF I. Development finance institution Proparco joined as a minority investor. Read more

Previous Next

STAY UP-TO-DATE ON EMERGING MARKETS PRIVATE CAPITAL ACTIVITY

Privacy Policy
Terms and Conditions
Sitemap

EMPEA Private Capital Virtual Resource

EMPEA is commited to providing research and intelligence, introductions, networking, and advocacy to drive sustainable growth in emerging markets.

Access details about these benefits and new initiatives that we expect to roll out in the coming months here.

Access EMPEA Private Capital Virtual Resource

Don't show this again

Subscribe to EMPEA Communications

Join today for exclusive benefits.

EMPEA is the global industry association for private capital in emerging markets. Subscribers can take advantage of special offers made by EMPEA or our partner companies. Click here to sign up.

In addition to these great free features, subscribers also have access to:

Weekly emerging markets private capital newsletter, NewsWatch
Invitations to industry events worldwide and in your market
Sector- and region-specific special reports and data releases

We respect your privacy and we won't share your information

Don't show this again